Rational Advisors LLC Astrazeneca PLC Transaction History

Rational Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$47.16 - $54.44 $91,867 - $106,049	-1,948 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$48.52 - $58.02 $94,516 - $113,022	1,948 New	1,948 $97,000
Q3 2019 Nov 06, 2019	SELL	$40.12 - $45.47 $709,522 - $804,136	-17,685 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$37.28 - $41.68 $659,296 - $737,110	17,685 New	17,685 $730,000
Q1 2019 May 08, 2019	SELL	$35.49 - $43.02 $9,298 - $11,271	-262 Closed	0 $0

Q4 2018 Feb 07, 2019	BUY	$36.86 - $41.49 $9,657 - $10,870	262 New	262 $10,000
Q4 2017 Feb 08, 2018	SELL	$32.09 - $34.78 $636,023 - $689,339	-19,820 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$28.96 - $34.0 $573,987 - $673,880	19,820	19,820 $672,000

1,248

477M

5.99M

5.24M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $239B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Rational Advisors LLC with notifications on news.